@inproceedings{inproceedings, title = {{Phase II study of bortezomib with cisplatin as first-line treatment of malignant pleural mesothelioma (MPM): EORTC 08052}}, url = {{}}, year = {{2012}}, month = {{5}}, author = {{O'Brien M and Gaafar RM and Popat S and Grossi F and Price A and Talbot DC and Cufer T and Ottensmeier CHH and Danson S and Pallis AG and Hasan B et al}}, volume = {{30}}, journal = {{JOURNAL OF CLINICAL ONCOLOGY}}, issue = {{15}}, note = {{Accessed on 2025/05/01}}}